ID   PHLD_HUMAN              Reviewed;         840 AA.
AC   P80108; Q15127; Q15128; Q2M2F2; Q5T3Y0; Q7Z6T8; Q8TCV0; Q8WW82; Q96ID6;
AC   Q9H167; Q9H4M1; Q9UJC9;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 3.
DT   07-APR-2021, entry version 169.
DE   RecName: Full=Phosphatidylinositol-glycan-specific phospholipase D;
DE            Short=PI-G PLD;
DE            EC=3.1.4.50;
DE   AltName: Full=Glycoprotein phospholipase D;
DE   AltName: Full=Glycosyl-phosphatidylinositol-specific phospholipase D;
DE            Short=GPI-PLD;
DE            Short=GPI-specific phospholipase D;
DE   Flags: Precursor;
GN   Name=GPLD1; Synonyms=PIGPLD1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS ILE-30; VAL-350;
RP   MET-461 AND ILE-698.
RC   TISSUE=Liver, and Pancreas;
RA   Tsang T.C., Fung W.-J.C., Levine J., Metz C.N., Davitz M.A., Burns D.K.,
RA   Huang K.-S., Kochan J.P.;
RT   "Isolation and expression of two human glycosylphosphatidylinositol
RT   phospholipase D (GPI-PLD) cDNAs.";
RL   FASEB J. 6:A1922-A1922(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), NUCLEOTIDE SEQUENCE [GENOMIC DNA]
RP   OF 384-840, AND VARIANTS ILE-30; VAL-694 AND ILE-698.
RC   TISSUE=Liver;
RX   PubMed=11072085; DOI=10.1016/s0167-4781(00)00194-9;
RA   Schofield J.N., Rademacher T.W.;
RT   "Structure and expression of the human glycosylphosphatidylinositol
RT   phospholipase D1 (GPLD1) gene.";
RL   Biochim. Biophys. Acta 1494:189-194(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ILE-698.
RC   TISSUE=Bone marrow;
RA   Tang J.H., Gu S.L., Zhang X.J.;
RT   "Preliminary study of the gene structure of human
RT   glycosylphosphatidylinositol specific phospholipase D.";
RL   Hunan Yi Ke Da Xue Xue Bao 26:96-97(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 266-840 (ISOFORM 1), AND VARIANTS VAL-17; ILE-30 AND
RP   ILE-698.
RC   TISSUE=Eye, and Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Serum;
RX   PubMed=1606959; DOI=10.1111/j.1432-1033.1992.tb16981.x;
RA   Hoener M.C., Brodbeck U.;
RT   "Phosphatidylinositol-glycan-specific phospholipase D is an amphiphilic
RT   glycoprotein that in serum is associated with high-density lipoproteins.";
RL   Eur. J. Biochem. 206:747-757(1992).
RN   [7]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-94.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J.,
RA   Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-659.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
CC   -!- FUNCTION: This protein hydrolyzes the inositol phosphate linkage in
CC       proteins anchored by phosphatidylinositol glycans (GPI-anchor) thus
CC       releasing these proteins from the membrane.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 6-(alpha-D-glucosaminyl)-1-phosphatidyl-1D-myo-inositol +
CC         H2O = 6-(alpha-D-glucosaminyl)-1D-myo-inositol + a 1,2-diacyl-sn-
CC         glycero-3-phosphate + H(+); Xref=Rhea:RHEA:10832, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57997, ChEBI:CHEBI:58608,
CC         ChEBI:CHEBI:58700; EC=3.1.4.50;
CC   -!- SUBUNIT: Monomer. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P80108-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P80108-2; Sequence=VSP_023261, VSP_023262;
CC   -!- SIMILARITY: Belongs to the GPLD1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA36444.1; Type=Miscellaneous discrepancy; Note=This sequence has numerous of conflicts with the human genome.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L11701; AAA36444.1; ALT_SEQ; mRNA.
DR   EMBL; L11702; AAA36445.1; -; mRNA.
DR   EMBL; AJ308108; CAC87068.1; -; mRNA.
DR   EMBL; AJ400872; CAC14844.1; -; Genomic_DNA.
DR   EMBL; AJ400873; CAC14844.1; JOINED; Genomic_DNA.
DR   EMBL; AJ400874; CAC14844.1; JOINED; Genomic_DNA.
DR   EMBL; AJ400875; CAC14844.1; JOINED; Genomic_DNA.
DR   EMBL; AJ400876; CAC14844.1; JOINED; Genomic_DNA.
DR   EMBL; AY007546; AAG16627.2; -; mRNA.
DR   EMBL; AL359713; CAI17103.1; -; Genomic_DNA.
DR   EMBL; AL031230; CAI17103.1; JOINED; Genomic_DNA.
DR   EMBL; AL031230; CAI22602.1; -; Genomic_DNA.
DR   EMBL; AL359713; CAI22602.1; JOINED; Genomic_DNA.
DR   EMBL; AL031230; CAD92520.1; -; Genomic_DNA.
DR   EMBL; BC007614; AAH07614.1; -; mRNA.
DR   EMBL; BC020748; AAH20748.1; -; mRNA.
DR   EMBL; BC093645; AAH93645.1; -; mRNA.
DR   EMBL; BC112001; AAI12002.1; -; mRNA.
DR   CCDS; CCDS4553.1; -. [P80108-1]
DR   RefSeq; NP_001494.2; NM_001503.3. [P80108-1]
DR   BioGRID; 109083; 6.
DR   IntAct; P80108; 1.
DR   STRING; 9606.ENSP00000230036; -.
DR   GlyConnect; 1601; 16 N-Linked glycans (6 sites).
DR   GlyGen; P80108; 12 sites, 4 N-linked glycans (3 sites).
DR   iPTMnet; P80108; -.
DR   PhosphoSitePlus; P80108; -.
DR   BioMuta; GPLD1; -.
DR   DMDM; 126302583; -.
DR   CPTAC; CPTAC-2231; -.
DR   jPOST; P80108; -.
DR   MassIVE; P80108; -.
DR   PaxDb; P80108; -.
DR   PeptideAtlas; P80108; -.
DR   PRIDE; P80108; -.
DR   ProteomicsDB; 57666; -. [P80108-1]
DR   ProteomicsDB; 57667; -. [P80108-2]
DR   Antibodypedia; 1368; 277 antibodies.
DR   DNASU; 2822; -.
DR   Ensembl; ENST00000230036; ENSP00000230036; ENSG00000112293. [P80108-1]
DR   GeneID; 2822; -.
DR   KEGG; hsa:2822; -.
DR   UCSC; uc003ned.3; human. [P80108-1]
DR   CTD; 2822; -.
DR   DisGeNET; 2822; -.
DR   GeneCards; GPLD1; -.
DR   HGNC; HGNC:4459; GPLD1.
DR   HPA; ENSG00000112293; Tissue enriched (liver).
DR   MIM; 602515; gene.
DR   neXtProt; NX_P80108; -.
DR   OpenTargets; ENSG00000112293; -.
DR   PharmGKB; PA28842; -.
DR   VEuPathDB; HostDB:ENSG00000112293.14; -.
DR   eggNOG; KOG3637; Eukaryota.
DR   GeneTree; ENSGT00390000013522; -.
DR   HOGENOM; CLU_011756_0_0_1; -.
DR   InParanoid; P80108; -.
DR   OMA; ADISWHS; -.
DR   OrthoDB; 743479at2759; -.
DR   PhylomeDB; P80108; -.
DR   TreeFam; TF335726; -.
DR   BRENDA; 3.1.4.50; 2681.
DR   PathwayCommons; P80108; -.
DR   Reactome; R-HSA-163125; Post-translational modification: synthesis of GPI-anchored proteins.
DR   SignaLink; P80108; -.
DR   BioGRID-ORCS; 2822; 1 hit in 986 CRISPR screens.
DR   ChiTaRS; GPLD1; human.
DR   GeneWiki; GPLD1; -.
DR   GenomeRNAi; 2822; -.
DR   Pharos; P80108; Tbio.
DR   PRO; PR:P80108; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P80108; protein.
DR   Bgee; ENSG00000112293; Expressed in liver and 184 other tissues.
DR   Genevisible; P80108; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0031012; C:extracellular matrix; ISS:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; HDA:UniProtKB.
DR   GO; GO:0004621; F:glycosylphosphatidylinositol phospholipase D activity; IDA:UniProtKB.
DR   GO; GO:0004630; F:phospholipase D activity; IDA:UniProtKB.
DR   GO; GO:0017080; F:sodium channel regulator activity; ISS:UniProtKB.
DR   GO; GO:0006501; P:C-terminal protein lipidation; TAS:Reactome.
DR   GO; GO:0002042; P:cell migration involved in sprouting angiogenesis; IMP:UniProtKB.
DR   GO; GO:0071277; P:cellular response to calcium ion; IDA:UniProtKB.
DR   GO; GO:0071397; P:cellular response to cholesterol; IMP:UniProtKB.
DR   GO; GO:0035690; P:cellular response to drug; IDA:UniProtKB.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IDA:UniProtKB.
DR   GO; GO:0071467; P:cellular response to pH; IDA:UniProtKB.
DR   GO; GO:0071401; P:cellular response to triglyceride; IMP:UniProtKB.
DR   GO; GO:0002062; P:chondrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0002430; P:complement receptor mediated signaling pathway; IDA:UniProtKB.
DR   GO; GO:0006507; P:GPI anchor release; IDA:UniProtKB.
DR   GO; GO:0035701; P:hematopoietic stem cell migration; TAS:UniProtKB.
DR   GO; GO:0097241; P:hematopoietic stem cell migration to bone marrow; TAS:UniProtKB.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IDA:UniProtKB.
DR   GO; GO:0010897; P:negative regulation of triglyceride catabolic process; ISS:UniProtKB.
DR   GO; GO:0001503; P:ossification; ISS:UniProtKB.
DR   GO; GO:0046470; P:phosphatidylcholine metabolic process; ISS:UniProtKB.
DR   GO; GO:0010694; P:positive regulation of alkaline phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0010595; P:positive regulation of endothelial cell migration; IMP:UniProtKB.
DR   GO; GO:0010907; P:positive regulation of glucose metabolic process; ISS:UniProtKB.
DR   GO; GO:0010983; P:positive regulation of high-density lipoprotein particle clearance; ISS:UniProtKB.
DR   GO; GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; ISS:UniProtKB.
DR   GO; GO:0051044; P:positive regulation of membrane protein ectodomain proteolysis; IDA:UniProtKB.
DR   GO; GO:0051047; P:positive regulation of secretion; ISS:UniProtKB.
DR   GO; GO:0010867; P:positive regulation of triglyceride biosynthetic process; ISS:UniProtKB.
DR   GO; GO:1900076; P:regulation of cellular response to insulin stimulus; IDA:UniProtKB.
DR   GO; GO:0009749; P:response to glucose; IDA:UniProtKB.
DR   GO; GO:0070633; P:transepithelial transport; ISS:UniProtKB.
DR   Gene3D; 2.130.10.130; -; 2.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR001028; Gprt_PLipase_D.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR028994; Integrin_alpha_N.
DR   InterPro; IPR029002; PLPC/GPLD1.
DR   Pfam; PF01839; FG-GAP; 3.
DR   Pfam; PF00882; Zn_dep_PLPC; 1.
DR   PRINTS; PR00718; PHPHLIPASED.
DR   SMART; SM00191; Int_alpha; 5.
DR   PROSITE; PS51470; FG_GAP; 7.
PE   1: Evidence at protein level;
KW   Alternative splicing; Direct protein sequencing; Glycoprotein; Hydrolase;
KW   Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL          1..23
FT   CHAIN           24..840
FT                   /note="Phosphatidylinositol-glycan-specific phospholipase
FT                   D"
FT                   /id="PRO_0000022047"
FT   REPEAT          367..428
FT                   /note="FG-GAP 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00803"
FT   REPEAT          436..497
FT                   /note="FG-GAP 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00803"
FT   REPEAT          499..559
FT                   /note="FG-GAP 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00803"
FT   REPEAT          563..623
FT                   /note="FG-GAP 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00803"
FT   REPEAT          633..693
FT                   /note="FG-GAP 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00803"
FT   REPEAT          704..770
FT                   /note="FG-GAP 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00803"
FT   REPEAT          788..840
FT                   /note="FG-GAP 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00803"
FT   CARBOHYD        94
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952"
FT   CARBOHYD        271
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        292
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        307
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        321
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        501
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        568
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        591
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        604
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        659
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   VAR_SEQ         165..176
FT                   /note="GDVLSQFEFNFN -> TVYLHLLNFLVV (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_023261"
FT   VAR_SEQ         177..840
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_023262"
FT   VARIANT         17
FT                   /note="L -> V (in dbSNP:rs2235501)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_030743"
FT   VARIANT         30
FT                   /note="V -> I (in dbSNP:rs1126617)"
FT                   /evidence="ECO:0000269|PubMed:11072085,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|Ref.1"
FT                   /id="VAR_030744"
FT   VARIANT         275
FT                   /note="D -> E (in dbSNP:rs17300770)"
FT                   /id="VAR_030745"
FT   VARIANT         350
FT                   /note="I -> V (in dbSNP:rs1062496)"
FT                   /evidence="ECO:0000269|Ref.1"
FT                   /id="VAR_051278"
FT   VARIANT         396
FT                   /note="G -> S (in dbSNP:rs6924628)"
FT                   /id="VAR_030746"
FT   VARIANT         461
FT                   /note="V -> M (in dbSNP:rs1062505)"
FT                   /evidence="ECO:0000269|Ref.1"
FT                   /id="VAR_030747"
FT   VARIANT         694
FT                   /note="M -> V (in dbSNP:rs1042303)"
FT                   /evidence="ECO:0000269|PubMed:11072085"
FT                   /id="VAR_030748"
FT   VARIANT         698
FT                   /note="T -> I (in dbSNP:rs1772256)"
FT                   /evidence="ECO:0000269|PubMed:11072085,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|Ref.1,
FT                   ECO:0000269|Ref.3"
FT                   /id="VAR_030749"
FT   CONFLICT        531..534
FT                   /note="VIGS -> MLGT (in Ref. 6; AA sequence)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   840 AA;  92336 MW;  11369BAFEC3D6D38 CRC64;
     MSAFRLWPGL LIMLGSLCHR GSPCGLSTHV EIGHRALEFL QLHNGRVNYR ELLLEHQDAY
     QAGIVFPDCF YPSICKGGKF HDVSESTHWT PFLNASVHYI RENYPLPWEK DTEKLVAFLF
     GITSHMAADV SWHSLGLEQG FLRTMGAIDF HGSYSEAHSA GDFGGDVLSQ FEFNFNYLAR
     RWYVPVKDLL GIYEKLYGRK VITENVIVDC SHIQFLEMYG EMLAVSKLYP TYSTKSPFLV
     EQFQEYFLGG LDDMAFWSTN IYHLTSFMLE NGTSDCNLPE NPLFIACGGQ QNHTQGSKMQ
     KNDFHRNLTT SLTESVDRNI NYTERGVFFS VNSWTPDSMS FIYKALERNI RTMFIGGSQL
     SQKHVSSPLA SYFLSFPYAR LGWAMTSADL NQDGHGDLVV GAPGYSRPGH IHIGRVYLIY
     GNDLGLPPVD LDLDKEAHRI LEGFQPSGRF GSALAVLDFN VDGVPDLAVG APSVGSEQLT
     YKGAVYVYFG SKQGGMSSSP NITISCQDIY CNLGWTLLAA DVNGDSEPDL VIGSPFAPGG
     GKQKGIVAAF YSGPSLSDKE KLNVEAANWT VRGEEDFSWF GYSLHGVTVD NRTLLLVGSP
     TWKNASRLGH LLHIRDEKKS LGRVYGYFPP NGQSWFTISG DKAMGKLGTS LSSGHVLMNG
     TLKQVLLVGA PTYDDVSKVA FLTVTLHQGG ATRMYALTSD AQPLLLSTFS GDRRFSRFGG
     VLHLSDLDDD GLDEIIMAAP LRIADVTSGL IGGEDGRVYV YNGKETTLGD MTGKCKSWIT
     PCPEEKAQYV LISPEASSRF GSSLITVRSK AKNQVVIAAG RSSLGARLSG ALHVYSLGSD
//
